Centiva Capital’s Bausch Health BHC Stock Holding History

Centiva Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-77,753	Closed	-$502K	–	1301
2025 Q3	$502K	Buy	77,753 +41,212	+113%	+$282K	﹤0.01%	639
2025 Q2	$243K	Buy	+36,541	New	+$188K	﹤0.01%	1257
2025 Q1	–	Sell	-47,607	Closed	-$384K	–	1569
2024 Q4	$384K	Sell	47,607 -68,984	-59%	-$569K	0.01%	992
2024 Q3	$951K	Buy	+116,591	New	+$768K	0.02%	875
2024 Q2	–	Sell	-59,377	Closed	-$630K	–	2067
2024 Q1	$630K	Sell	59,377 -23,028	-28%	-$201K	0.02%	885
2023 Q4	$661K	Buy	+82,405	New	+$600K	0.02%	821
2023 Q3	–	Sell	-25,134	Closed	-$201K	–	1723
2023 Q2	$201K	Buy	+25,134	New	+$185K	﹤0.01%	1337
2020 Q1	–	Sell	-7,778	Closed	-$233K	–	630
2019 Q4	$233K	Buy	+7,778	New	+$202K	0.01%	629

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Centiva Capital's BHC Position: Q4 2025 in Review

Centiva Capital sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 77,753 shares — an estimated $502K sold.

Centiva Capital first reported a position in BHC in Q4 2019 and held it in 8 quarters. The position peaked at $951K in Q3 2024. 236 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

Centiva Capital reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
Centiva Capital sold 77,753 Bausch Health shares in Q4 2025, an estimated $502K.
Centiva Capital first reported a position in Bausch Health in Q4 2019 and held it in 8 quarters.
Centiva Capital's Bausch Health position peaked at $951K in Q3 2024.
236 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.